[PDF][PDF] Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP
Cancer cell, 2014•cell.com
Uveal melanoma (UM) is the most common cancer in adult eyes. Approximately 80% of UMs
harbor somatic activating mutations in GNAQ or GNA11 (encoding Gq or G11, respectively).
Herein, we show in both cell culture and human tumors that cancer-associated Gq/11
mutants activate YAP, a major effector of the Hippo tumor suppressor pathway that is also
regulated by G protein-coupled receptor signaling. YAP mediates the oncogenic activity of
mutant Gq/11 in UM development, and the YAP inhibitor verteporfin blocks tumor growth of …
harbor somatic activating mutations in GNAQ or GNA11 (encoding Gq or G11, respectively).
Herein, we show in both cell culture and human tumors that cancer-associated Gq/11
mutants activate YAP, a major effector of the Hippo tumor suppressor pathway that is also
regulated by G protein-coupled receptor signaling. YAP mediates the oncogenic activity of
mutant Gq/11 in UM development, and the YAP inhibitor verteporfin blocks tumor growth of …
Summary
Uveal melanoma (UM) is the most common cancer in adult eyes. Approximately 80% of UMs harbor somatic activating mutations in GNAQ or GNA11 (encoding Gq or G11, respectively). Herein, we show in both cell culture and human tumors that cancer-associated Gq/11 mutants activate YAP, a major effector of the Hippo tumor suppressor pathway that is also regulated by G protein-coupled receptor signaling. YAP mediates the oncogenic activity of mutant Gq/11 in UM development, and the YAP inhibitor verteporfin blocks tumor growth of UM cells containing Gq/11 mutations. This study reveals an essential role of the Hippo-YAP pathway in Gq/11-induced tumorigenesis and suggests YAP as a potential drug target for UM patients carrying mutations in GNAQ or GNA11.
cell.com
